Skip to main content
NIH funding notice PAR-14-288

NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (UH2/UH3)

Closed on September 7, 2017.

Posted
July 18, 2014
Close date
September 7, 2017
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,135,776 in first-year total cost, median $1,135,776.

Most frequent study sections

  1. Neurological Sciences and Disorders B Study Section[NSD-B]1

Most frequent institutions

  1. CHILDREN'S HOSP OF PHILADELPHIA1
Competing awards under PAR-14-288 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2016RNAi Therapy for Spinocerebellar Ataxia Type 11UH2NS094355-01DAVIDSON, BEVERLY L.CHILDREN'S HOSP OF PHILADELPHIA, PA$1,135,776NSD

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.